$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹1202
INTRODUCTION COGNITRAC 60MG INJECTION contains Cerebroprotein Hydrolysate which belongs to group of medicines called Neurotrophic agents. It is used to treat cranial injury, aprosexia (inability to concentrate) in dementia, cerebrovascular disease that includes stroke, and Alzheimer's disease....
COGNITRAC 60MG INJECTION contains Cerebroprotein Hydrolysate which belongs to group of medicines called Neurotrophic agents. It is used to treat cranial injury, aprosexia (inability to concentrate) in dementia, cerebrovascular disease that includes stroke, and Alzheimer's disease.
A cranial injury is a head injury causing trauma to the scalp, skull, or brain. It is characterised by symptoms such as leakage of blood outside the blood vessels, uncontrolled bleeding, skull fracture, brain injury, or swelling in the brain.
A stroke occurs when the blood supply to the brain or part of it is blocked. It is characterised by symptoms such as troubled speech, numbness in the body, visual disturbances, headaches, and troubled waking.
Dementia is a group of symptoms such as loss of memory and thinking/reasoning abilities. Alzheimer’s disease is a disorder that causes progressive degeneration of brain cells, resulting in brain shrinkage. It is characterised by dementia, social withdrawal, and wandering.
COGNITRAC 60MG INJECTION is not recommended for use in patients with severe renal dysfunction, status epilepticus (a life-threatening neurological disorder), or major epilepsia (a seizure that causes loss of consciousness and violent muscle contractions).
COGNITRAC 60MG INJECTION should be used with caution in patients with epilepsy (fits or seizures) and or allergic diathesis (condition causing predisposition to develop group of allergies such as hay fever, allergic rhinitis, bronchial asthma, or atopic dermatitis).
COGNITRAC 60MG INJECTION should be used with caution in pregnant and breastfeeding females only if it is clearly needed. COGNITRAC 60MG INJECTION should be used with caution in elderly patients (above 65 years). Consult your doctor before receiving it.
The common side effects associated with the use of COGNITRAC 60MG INJECTION are headache, nausea, vertigo (sensation of spinning), increased sweating, agitation, fever, and hallucinations. Consult your doctor if any of the symptoms worsen.
COGNITRAC 60MG INJECTION helps in restoring brain functions where Cerebroprotein Hydrolysate works by protecting nerve cells from toxins and lack of oxygen. It improves the survival ability of nerve cells. It also helps in the formation of new nerve cells, increasing nutrition of brain cells, reducing inflammation of brain tissues, and blocking the release of certain chemicals that may damage brain cells.
COGNITRAC 60MG INJECTION will be given to you only by a doctor or a nurse into the vein. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop receiving COGNITRAC 60MG INJECTION and contact your doctor if you experience any of the following side effects:
Try to eat more high-fibre foods, such as fresh fruit, vegetables, and cereals, and drink plenty of water. Exercise regularly or go for a daily walk or run. If this does not help, inform your doctor about receiving alternate treatments for constipation.
Drink lots of fluids, such as water, to keep yourself hydrated. Try to avoid receiving any medicine on your own to treat diarrhoea, and consult your doctor if the symptom gets worse.
Take rest and drink plenty of water. Avoid receiving alcohol and skipping meals. Do not strain your eyes by watching the screen for a long time. Consult your doctor if the condition persists for a long time or gets worse.
Try to take COGNITRAC 60MG INJECTION with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if the symptom gets worse.
COGNITRAC 60MG INJECTION should be used cautiously in pregnant females only if it is considered clearly necessary. Consult your doctor before receiving it.
COGNITRAC 60MG INJECTION should be used cautiously in breastfeeding mothers only if it is considered clearly necessary. Consult your doctor before receiving it.
Do not drive or operate machines after receiving COGNITRAC 60MG INJECTION to avoid any possible risk. Consult your doctor before receiving it.
Consult your doctor before receiving COGNITRAC 60MG INJECTION if alcohol is planned to be consumed.
COGNITRAC 60MG INJECTION is not recommended for use in patients with severe renal dysfunction. It should be used with caution in patients with other kidney problems. Consult your doctor before receiving it.
COGNITRAC 60MG INJECTION should be used with caution in patients with liver disease. Consult your doctor before taking COGNITRAC 60MG INJECTION.
COGNITRAC 60MG INJECTION is not recommended for use if you are allergic to cerebroprotein hydrolysate, or any other ingredients of this medicine. Consult your doctor before receiving it.
COGNITRAC 60MG INJECTION should be used with caution in children. Consult your doctor before receiving COGNITRAC 60MG INJECTION.
COGNITRAC 60MG INJECTION should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before receiving COGNITRAC 60MG INJECTION.
COGNITRAC 60MG INJECTION is not recommended for use if you:
Before receiving COGNITRAC 60MG INJECTION, inform your doctor if you:
A. Drug-Drug Interactions:
Before receiving COGNITRAC 60MG INJECTION, inform your doctor, if you are taking any of the following medicine:
Overdosage:
COGNITRAC 60MG INJECTION will be given to you only by a doctor or nurse in a hospital, and so it is unlikely to receive an overdose. However, if you experience any unusual symptoms, consult your doctor immediately or visit the nearby hospital.
| Drug | : | Cerebroprotein hydrolysate |
| Pharmacological Category | : | Neurotrophic agents |
| Therapeutic Indication | : | Cranial injury, Aprosexia (inability to concentrate) in dementia, Cerebrovascular disease including stroke, Alzheimer's disease |
| Dosage Forms | : | Injection, Tablet |
Q: What is COGNITRAC 60MG INJECTION used for?
A: COGNITRAC 60MG INJECTION is used to treat cranial injury, aprosexia (inability to concentrate) in dementia, cerebrovascular disease that includes stroke, and Alzheimer's disease. Consult your doctor before receiving COGNITRAC 60MG INJECTION.
Q: What happens if you take more COGNITRAC 60MG INJECTION than your required dose?
A: COGNITRAC 60MG INJECTION will be given to you only by a doctor or nurse in a hospital, and so it is unlikely that you will receive an overdose. However, if you experience any unusual symptoms, consult your doctor immediately or visit the nearby hospital.
Q: What side effects are seen with COGNITRAC 60MG INJECTION?
A: The common side effects associated with the use of COGNITRAC 60MG INJECTION are headache, nausea, vertigo (sensation of spinning), increased sweating, agitation, fever, and hallucinations. Consult your doctor if any of the symptoms worsen.
Q: Who should avoid receiving COGNITRAC 60MG INJECTION?
A: COGNITRAC 60MG INJECTION is not recommended for use in patients allergic to cerebroprotein hydrolysate or with severe renal dysfunction, status epilepticus (a life-threatening neurological disorder), or major epilepsia (a seizure that causes loss of consciousness and violent muscle contractions). Consult your doctor before receiving COGNITRAC 60MG INJECTION.
Q: Is COGNITRAC 60MG INJECTION safe to use in elderly patients?
A: COGNITRAC 60MG INJECTION should be used with caution in elderly patients (aged 65 years and above), especially in those who do not respond to anticholinesterases. Consult your doctor before receiving COGNITRAC 60MG INJECTION.
Q: How does COGNITRAC 60MG INJECTION work?
A: COGNITRAC 60MG INJECTION helps in restoring brain functions, where Cerebroprotein Hydrolysate works by protecting nerve cells from toxins and a lack of oxygen. It improves the survival ability of nerve cells. It also helps in the formation of new nerve cells, increases the nutrition of brain cells, reduces inflammation of brain tissues, and blocks the release of certain chemicals that may damage brain cells.
Q: Can I drive while receiving alcohol?
A: Do not drive vehicles, operate machines, or do any hazardous activity after receiving COGNITRAC 60MG INJECTION to avoid any possible risk as this medicine may cause vertigo. Consult your doctor before receiving COGNITRAC 60MG INJECTION.
Q: What is the method of receiving COGNITRAC 60MG INJECTION?
A: COGNITRAC 60MG INJECTION will be given to you only by a doctor or a nurse and placed into the vein. Your doctor will determine the correct dose and duration for you depending upon your age, body weight, and disease condition.
Q: What medication’s intake should be lowered while receiving COGNITRAC 60MG INJECTION?
A: Before receiving COGNITRAC 60MG INJECTION, inform your doctor if you are taking medicines that are used to treat depression, such as monoamine oxidase inhibitors (MAOIs), such as phenelzine.
Q: Can COGNITRAC 60MG INJECTION cause flu?
A: Yes. COGNITRAC 60MG INJECTION may cause flu-like symptoms such as fever, chills, sore throat, and cough in some patients, which are generally temporary and resolve with time. However, contact your doctor if this condition worsens.
1. Perry B. Molinoff. Neurotransmission and the Central Nervous System. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. Twelfth Edition. 2011. Page – 375.
2. Mosam Phirke, Avinash Desousa, Nilesh Shah, Sushma Sonavane, Anup Bharati. The use of cerebroprotein hydrolysate in dementia: A case series of 25 cases seen in a tertiary general hospital. Journal of geriatric mental health. 2014. [Accessed 7th July 2022] https://www.jgmh.org/article.asp?issn=2348-9995;year=2014;volume=1;issue=2;spage=106;epage=109;aulast=Phirke
3. Fanbing Kong, Hujie Song. Progress in Treatment of Spastic Cerebral Palsy with Integrated Traditional Chinese and Western Medicine. Clausius Scientific Press. MEDS Clinical Medicine. 2021. [Accessed 7th July 2022] http://clausiuspress.com/assets/default/article/2021/11/24/article_1637736393.pdf
4. Ciplamed. CEREBROCIP Injection (Cerebroprotein hydrolysate). [Revised in August 2017] [Accessed 7th July 2022] https://www.ciplamed.com/content/cerebrocip-injection
5. Medicrit Biotech Private Limited. Cerbocin 60 MG Injection. [Accessed 7th July 2022] https://www.medicrit.co.in/product/cerbocin-60mg-injection/
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 05 Apr 2023 | 10:37 AM(IST)